Sign in
8-K

Current Report

CNS Pharmaceuticals, Inc. Filed Acc 0001683168-23-005787

Bylaws or fiscal year change

  • Item 5.03 Amendments to articles or bylaws; change in fiscal year

From the SEC's structured data for this filing